Search research articles
Contact Us
Filters
Showing results (101-110 of 184) with videos related to
Page
of 19
Sort By:
Cytotherapy
|
April 24, 2019
NK92-CD16 cells are cytotoxic to non-small cell lung cancer cell lines that have acquired resistance to tyrosine kinase inhibitors
Ha-Ram Park, Yong-Oon Ahn, Tae Min Kim, et al.
Molecular Cancer Therapeutics
|
December 13, 2019
Clinical Application of Next-Generation Sequencing-Based Panel to <i>BRAF</i> Wild-Type Advanced Melanoma Identifies Key Oncogenic Alterations and Therapeutic Strategies
Changhee Park, Miso Kim, Min Jung Kim, et al.
Journal of Biomedical Nanotechnology
|
August 25, 2015
Functionalized Polyacrylonitrile Nanofibrous Membranes for Covalent Immobilization of Glucose Oxidase
James Manuel, Miso Kim, Rohini Dharela, et al.
The Korean Journal of Internal Medicine
|
September 3, 2020
Temporal evolution of programmed death-ligand 1 expression in patients with non-small cell lung cancer
Chang Hyun Nam, Jaemoon Koh, Chan-Young Ock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 29, 2016
Pan-Cancer Immunogenomic Perspective on the Tumor Microenvironment Based on PD-L1 and CD8 T-Cell Infiltration
Chan-Young Ock, Bhumsuk Keam, Sehui Kim, et al.
Frontiers in Oncology
|
June 18, 2024
Avelumab first-line maintenance treatment in patients with locally advanced or metastatic urothelial carcinoma: real-world results from a Korean expanded access program
Se Hoon Park, Sang Joon Shin, Sun Young Rha, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 10, 2024
A phase II study of osimertinib in patients with NSCLC harboring EGFR exon 20 insertion: A multicenter trial of the Korean Cancer Study Group (LU17-19)
Yu Jung Kim, Soyeon Kim, Tae Min Kim, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 9, 2021
Acquired Resistance to Third-Generation EGFR Tyrosine Kinase Inhibitors in Patients With De Novo EGFR<sup>T790M</sup>-Mutant NSCLC
Ha-Ram Park, Tae Min Kim, Yusoo Lee, et al.
Cancer Research and Treatment
|
January 8, 2024
Analytical and Clinical Validation of a Highly Sensitive NGS-Based ctDNA Assay with Real-World Concordance in Non-Small Cell Lung Cancer
Hanbaek Yi, Jeonghwan Youk, Yoojoo Lim, et al.
Annals of Hematology
|
October 11, 2014
Ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) plus L-asparaginase as a first-line therapy improves outcomes in stage III/IV NK/T cell-lymphoma, nasal type (NTCL)
Miso Kim, Tae Min Kim, Ki Hwan Kim, et al.
Page
of 19
Search research articles
Search
Showing results (101-110 of 184) with videos related to
Sort By:
Page
of 19
Cytotherapy
|
April 24, 2019
NK92-CD16 cells are cytotoxic to non-small cell lung cancer cell lines that have acquired resistance to tyrosine kinase inhibitors
Ha-Ram Park, Yong-Oon Ahn, Tae Min Kim, et al.
Molecular Cancer Therapeutics
|
December 13, 2019
Clinical Application of Next-Generation Sequencing-Based Panel to <i>BRAF</i> Wild-Type Advanced Melanoma Identifies Key Oncogenic Alterations and Therapeutic Strategies
Changhee Park, Miso Kim, Min Jung Kim, et al.
Journal of Biomedical Nanotechnology
|
August 25, 2015
Functionalized Polyacrylonitrile Nanofibrous Membranes for Covalent Immobilization of Glucose Oxidase
James Manuel, Miso Kim, Rohini Dharela, et al.
The Korean Journal of Internal Medicine
|
September 3, 2020
Temporal evolution of programmed death-ligand 1 expression in patients with non-small cell lung cancer
Chang Hyun Nam, Jaemoon Koh, Chan-Young Ock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 29, 2016
Pan-Cancer Immunogenomic Perspective on the Tumor Microenvironment Based on PD-L1 and CD8 T-Cell Infiltration
Chan-Young Ock, Bhumsuk Keam, Sehui Kim, et al.
Frontiers in Oncology
|
June 18, 2024
Avelumab first-line maintenance treatment in patients with locally advanced or metastatic urothelial carcinoma: real-world results from a Korean expanded access program
Se Hoon Park, Sang Joon Shin, Sun Young Rha, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 10, 2024
A phase II study of osimertinib in patients with NSCLC harboring EGFR exon 20 insertion: A multicenter trial of the Korean Cancer Study Group (LU17-19)
Yu Jung Kim, Soyeon Kim, Tae Min Kim, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 9, 2021
Acquired Resistance to Third-Generation EGFR Tyrosine Kinase Inhibitors in Patients With De Novo EGFR<sup>T790M</sup>-Mutant NSCLC
Ha-Ram Park, Tae Min Kim, Yusoo Lee, et al.
Cancer Research and Treatment
|
January 8, 2024
Analytical and Clinical Validation of a Highly Sensitive NGS-Based ctDNA Assay with Real-World Concordance in Non-Small Cell Lung Cancer
Hanbaek Yi, Jeonghwan Youk, Yoojoo Lim, et al.
Annals of Hematology
|
October 11, 2014
Ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) plus L-asparaginase as a first-line therapy improves outcomes in stage III/IV NK/T cell-lymphoma, nasal type (NTCL)
Miso Kim, Tae Min Kim, Ki Hwan Kim, et al.
Page
of 19